Aplastic Anemia Treatment
Hematology
Kuanzia
$15,000
Hadi $90,000 kulingana na kituo
Muda wa kawaida
45–100 days
Ikiwemo uchunguzi wa kabla ya upasuaji
Hospitali washirika
0
Zimechunguzwa kwa data ya matokeo na vyeti
Muhtasari
Pokea matibabu yanayoweza kupona kwa anemia ya aplastic kali kupitia upandikizaji wa uboho au tiba ya kukandamiza kinga yenye ufanisi mkubwa (IST) na anti-thymocyte globulin na cyclosporine. India na Israel zinatoa mipango ya hali ya kwanza ya anemia ya aplastic na madaktari wa hematologia wenye uzoefu kwa gharama 60–80% chini ya nchi za Magharibi.
Kesi yako inalinganishwa na kituo kwa msingi wa data ya matokeo ya kitabibu, si matangazo. Tunaratibu kila hatua — kuanzia uchunguzi wa kabla ya upasuaji hadi ufuatiliaji wa baada ya matibabu — pamoja na mratibu maalum wa huduma.
Kinachojumuishwa
Aplastic Anemia Treatment
Imeratibiwa kuanzia
au tutumie ujumbe kwenye WhatsApp
Hakuna ahadi inayohitajika. Data yako kamwe haishirikiwi na wahusika wengine.
Ulinganisho wa gharama duniani — Aplastic Anemia Treatment
Wastani wa gharama zilizoratibiwa katika vituo vyetu washirika. Bei ya mwisho inategemea uzito wa kitabibu na hospitali iliyochaguliwa.
| Nchi | Wastani wa gharama | ikilinganishwa na ya bei nafuu zaidi |
|---|---|---|
🇮🇳 India New Delhi · Chennai · Bengaluru · Hyderabad · Mumbai · Kochi | $18,000 | —chevron_right |
🇹🇷 Turkey Istanbul | $75,000 | +317%chevron_right |
Gharama ni za makadirio na zinapitiwa kila robo mwaka. Omba makadirio ya kibinafsi kwa kesi yako mahususi.
Maswali yanayoulizwa mara kwa mara
The choice depends primarily on age, disease severity, and donor availability. For patients under 40 with severe or very severe aplastic anemia who have a matched sibling donor, bone marrow transplant is the preferred curative option with long-term success rates above 85%. For older patients, those without a matched donor, or those with non-severe disease, immunosuppressive therapy with horse-ATG or rabbit-ATG plus cyclosporine is the standard first-line approach, achieving responses in 60–70% of patients. Our partner hematologists will review your CBC, bone marrow biopsy, and HLA typing to provide a tailored recommendation before you travel.
Hakuna ada. Hakuna ahadi.
Muongozo wetu ni wa bure kabisa
Tunalipwa na hospitali zetu washirika — kamwe na wagonjwa. Unapata ulinganishaji huru wa kitabibu, uwazi wa gharama, na uratibu kamili bila gharama kwako.